Petr Dušek

Cited by

	All	Since 2019
Citations	6006	4871
h-index	41	34
i10-index	83	77

1200

600

300

900

2011201220132014201520162017201820192020202120222023202430 46 85 98 121 176 213 235 398 586 765 1031 1129 936

Public access

View all

27 articles

5 articles

available

not available

Based on funding mandates

Co-authors

Tomasz LitwinDr hab n.med II Klinika Neurologii, Instytut Psychiatrii i Neurologii, Warszawa, PolskaVerified email at medprakt.pl
Jan RuszCzech Technical University in Prague; Charles University in PragueVerified email at fel.cvut.cz
Karel ŠonkaDepartment of Neurology, First Faculty of Medicine, Charles University and General UniversityVerified email at lf1.cuni.cz
Ondrej BezdicekProfessor (full), Diamant Neuropsychology Laboratory, Department of Neurology and Centre ofVerified email at vfn.cz
Thoralf NiendorfProfessor for Exprimental Ultrahigh Field MR, Charite, Berlin & Head, Berlin Ultrahigh FieldVerified email at mdc-berlin.de
Tereza TykalováCzech Technical University in PragueVerified email at fel.cvut.cz
Michal NovotnýCzech Technical University in Prague, Faculty of Electrical EngineeringVerified email at fel.cvut.cz
Friedemann PaulProfessor für klinische Neuroimmunologie, Charité Universitätsmedizin BerlinVerified email at charite.de
Tomas SiegerResearcher at the Czech Technical UniversityVerified email at fel.cvut.cz
Radim KrupičkaCzech Technical University in PragueVerified email at fbmi.cvut.cz
Vince Istvan MadaiM.D., Ph.D., M.A., @QUEST, Charité BerlinVerified email at charite.de
Jan RothCharles University 1st Medical Faculty Dept. of NeurologyVerified email at lf1.cuni.cz
Yulin GeProfessor or Radiology, New York University School of MedicineVerified email at nyumc.org
Ilya KisterNYU School of MedicineVerified email at nyumc.org
Julio Acosta-CabroneroHead of R&D at Luminance TechnologiesVerified email at luminance.com
Per M RoosMD PhD IMM Karolinska InstitutetVerified email at ki.se
Valentina MediciUniversity of California DavisVerified email at ucdavis.edu
Jan StochlUniversity of Cambridge, Charles UniversityVerified email at cam.ac.uk
Jan HlavničkaCTUVerified email at fel.cvut.cz
Trond Peder FlatenDepartment of Chemistry, Norwegian University of Science and TechnologyVerified email at ntnu.no

Petr Dušek

Department of Neurology and Center of Clinical Neuroscience, Charles University, 1st Medical Faculty

Verified email at vfn.cz

neurodegeneration neuroimaging metals NBIA Wilson disease


Title Sort by citations Sort by year Sort by title	Cited by Cited by	Year
Risk and predictors of dementia and parkinsonism in idiopathic REM sleep behaviour disorder: a multicentre study RB Postuma, A Iranzo, M Hu, B Högl, BF Boeve, R Manni, WH Oertel, ... Brain 142 (3), 744-759, 2019	789	2019
Wilson disease A Członkowska, T Litwin, P Dusek, P Ferenci, S Lutsenko, V Medici, ... Nature Reviews Disease Primers 4 (1), 21, 2018	738	2018
The neurotoxicity of iron, copper and manganese in Parkinson's and Wilson's diseases P Dusek, PM Roos, T Litwin, SA Schneider, TP Flaten, J Aaseth Journal of trace elements in medicine and biology 31, 193-203, 2015	275	2015
Iron dysregulation in movement disorders P Dusek, J Jankovic, W Le Neurobiology of disease 46 (1), 1-18, 2012	216	2012
Biomarkers of conversion to α-synucleinopathy in isolated rapid-eye-movement sleep behaviour disorder MG Miglis, CH Adler, E Antelmi, D Arnaldi, L Baldelli, BF Boeve, M Cesari, ... The Lancet Neurology 20 (8), 671-684, 2021	165	2021
Genetics and pathophysiology of neurodegeneration with brain iron accumulation (NBIA) S A Schneider, P Dusek, J Hardy, A Westenberger, J Jankovic, K P Bhatia Current neuropharmacology 11 (1), 59-79, 2013	140	2013
Safety and efficacy of deferiprone for pantothenate kinase-associated neurodegeneration: a randomised, double-blind, controlled trial and an open-label extension study T Klopstock, F Tricta, L Neumayr, I Karin, G Zorzi, C Fradette, T Kmieć, ... The Lancet Neurology 18 (7), 631-642, 2019	126	2019
Iron chelation in the treatment of neurodegenerative diseases P Dusek, SA Schneider, J Aaseth Journal of Trace Elements in Medicine and Biology 38, 81-92, 2016	124	2016
Pathogenesis of Wilson disease IF Scheiber, R Brůha, P Dušek Handbook of clinical neurology 142, 43-55, 2017	116	2017
Psychiatric manifestations in Wilson’s disease: possibilities and difficulties for treatment T Litwin, P Dusek, T Szafrański, K Dzieżyc, A Członkowska, ... Therapeutic advances in psychopharmacology 8 (7), 199-211, 2018	114	2018
Smartphone allows capture of speech abnormalities associated with high risk of developing Parkinson’s disease J Rusz, J Hlavnička, T Tykalová, M Novotný, P Dušek, K Šonka, E Růžička IEEE transactions on neural systems and rehabilitation engineering 26 (8 …, 2018	109	2018
Repetitive TMS of the somatosensory cortex improves writer’s cramp and enhances cortical activity P Havrankova, R Jech, ND Walker, G Operto, J Tauchmanova, J Vymazal, ... Neuroendocrinol Lett 31 (1), 73-86, 2010	104	2010
Trial of deferiprone in Parkinson’s disease D Devos, J Labreuche, O Rascol, JC Corvol, A Duhamel, ... New England Journal of Medicine 387 (22), 2045-2055, 2022	97	2022
Speech biomarkers in rapid eye movement sleep behavior disorder and Parkinson disease J Rusz, J Hlavnička, M Novotný, T Tykalová, A Pelletier, J Montplaisir, ... Annals of neurology 90 (1), 62-75, 2021	97	2021
Dopaminergic imaging and clinical predictors for phenoconversion of REM sleep behaviour disorder D Arnaldi, A Chincarini, MT Hu, K Sonka, B Boeve, T Miyamoto, ... Brain 144 (1), 278-287, 2021	97	2021
Treatment strategies in Alzheimer’s disease: a review with focus on selenium supplementation J Aaseth, J Alexander, G Bjørklund, K Hestad, P Dusek, PM Roos, ... Biometals 29, 827-839, 2016	90	2016
Wilson disease and other neurodegenerations with metal accumulations P Dusek, T Litwin, A Czlonkowska Neurologic clinics 33 (1), 175-204, 2015	90	2015
Neurologic impairment in Wilson disease P Dusek, T Litwin, A Członkowska Annals of translational medicine 7 (Suppl 2), 2019	88	2019
BRAVE-NET: fully automated arterial brain vessel segmentation in patients with cerebrovascular disease A Hilbert, VI Madai, EM Akay, OU Aydin, J Behland, J Sobesky, I Galinovic, ... Frontiers in artificial intelligence 3, 552258, 2020	87	2020
Prevention of progression in Parkinson’s disease J Aaseth, P Dusek, PM Roos Biometals 31, 737-747, 2018	85	2018

The system can't perform the operation now. Try again later.

Articles 1–20

Citations per year

Duplicate citations

Merged citations

Add co-authorsCo-authors

Follow

Cited by

Co-authors